Article
Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Cancer biomarkers : section A of Disease markers - 1 Jan 2019
Zhang Huiping, Wang Jianfeng, Wang Zhanying, Ruan Cailian, Wang Lu, Guo Hongtao
Abstract excerpt
BACKGROUND: It is well known that some circulating microRNAs (miRNAs) are highly stable and might serve as promising biomarkers for many types of human cancer including glioblastoma (GBM). However, the potential clinical significance of serum miR-100 in GBM remained unknown. OBJECTIVE: We aimed to detect the expression level of serum miR-100 in patients with GBM and assess its potential diagnostic and prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.